United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

Currently, United Therapeutics has a market capitalization of $16.17 billion. Buying $1000 In UTHR: If an investor had bought $1000 of UTHR stock 20 years ago, it would be worth $16,173.45 today ...

In this article, we are going to take a look at where United Therapeutics Corporation ... matching that of small-cap stocks, indicating a change in market dynamics. Biotech may increase if ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

Strength Seen in Foghorn Therapeutics: Can Its 9.5% Jump Turn into More Strength? Foghorn Therapeutics Inc. (NASDAQ: FHTX) shares rallied 9.5% in the last trading session to close at $9.72.

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic ...